Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Cancer Letters|May 26, 2004
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
Cancer Research|July 20, 2006
Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancerCharles Spruck, Dahui Sun, Heidi Fiegl, et al.
Ebiomedicine|December 3, 2015
A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier StateYing Liu, Hai-Yun Yen, Theresa Austria, et al.
Cancer Research|February 11, 2014
PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancerYingmeei Tan, Dahui Sun, Weijian Jiang, et al.
Cancer Research|March 1, 2005
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patientsHeidi Fiegl, Simone Millinger, Elisabeth Mueller-Holzner, et al.
Plos One|July 17, 2008
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle studyMartin Widschwendter, Sophia Apostolidou, Elke Raum, et al.
Scientific Reports|October 25, 2013
Cellular network entropy as the energy potential in Waddington's differentiation landscapeChristopher R S Banerji, Diego Miranda-Saavedra, Simone Severini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2011
Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteinsVasco Liberal, Hanna-Stina Martinsson-Ahlzén, Jennifer Liberal, et al.
Nature Medicine|June 4, 2024
Cervical cancer screening using DNA methylation triage in a real-world populationLena Schreiberhuber, James E Barrett, Jiangrong Wang, et al.
Nature Communications|January 30, 2016
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancerAndrew E Teschendorff, Yang Gao, Allison Jones, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Cancer Letters|May 26, 2004
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
Cancer Research|July 20, 2006
Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancerCharles Spruck, Dahui Sun, Heidi Fiegl, et al.
Ebiomedicine|December 3, 2015
A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier StateYing Liu, Hai-Yun Yen, Theresa Austria, et al.
Cancer Research|February 11, 2014
PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancerYingmeei Tan, Dahui Sun, Weijian Jiang, et al.
Cancer Research|March 1, 2005
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patientsHeidi Fiegl, Simone Millinger, Elisabeth Mueller-Holzner, et al.
Plos One|July 17, 2008
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle studyMartin Widschwendter, Sophia Apostolidou, Elke Raum, et al.
Scientific Reports|October 25, 2013
Cellular network entropy as the energy potential in Waddington's differentiation landscapeChristopher R S Banerji, Diego Miranda-Saavedra, Simone Severini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2011
Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteinsVasco Liberal, Hanna-Stina Martinsson-Ahlzén, Jennifer Liberal, et al.
Nature Medicine|June 4, 2024
Cervical cancer screening using DNA methylation triage in a real-world populationLena Schreiberhuber, James E Barrett, Jiangrong Wang, et al.
Nature Communications|January 30, 2016
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancerAndrew E Teschendorff, Yang Gao, Allison Jones, et al.
Pageof 18